{"id":3565,"count":7,"description":"Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder affecting 5\u201310% of adults, characterised by abdominal pain associated with altered bowel habit. Inflammatory bowel disease (IBD \u2014 ulcerative colitis and Crohn's disease) is a distinct group of immune-mediated chronic inflammatory conditions affecting younger adults disproportionately. The MedsBase IBS Treatment catalogue groups medications for both. Megjegyz\u00e9s:<\/strong> the category name historically said \"IBS\" but most products are IBD-specific (mesalamine, sulfasalazine) \u2014 we are reorganising. All products are supplied by WHO-GMP tan\u00fas\u00edtv\u00e1nnyal rendelkez\u0151 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmazik<\/strong>.\n\n5-ASA \/ meszalamin \u2014 ulcerat\u00edv colitis fenntart\u00f3 kezel\u00e9s\u00e9re \u00e9s enyhe-k\u00f6zepes fell\u00e1ngol\u00e1sokra.<\/strong> Az or\u00e1lis meszalamin (5-aminoszalicilsav) els\u0151 vonalbeli karbantart\u00f3 kezel\u00e9s\u0171 ulcerat\u00edv colitiszban \u00e9s enyhe-k\u00f6zepes rohamok eset\u00e9n hat\u00e9kony. A k\u00fcl\u00f6nb\u00f6z\u0151 m\u00e1rk\u00e1k elt\u00e9rnek a felszabadul\u00e1si mint\u00e1zatban (pH-f\u00fcgg\u0151 lass\u00fa felszabadul\u00e1s\u00fa, id\u0151f\u00fcgg\u0151, multi-m\u00e1trix), ami meghat\u00e1rozza, hogy a gy\u00f3gyszer hol szabadul fel a b\u00e9lben \u2014 a m\u00e1rka v\u00e1laszt\u00e1s\u00e1t a betegs\u00e9g eloszl\u00e1s\u00e1nak megfelel\u0151en kell meghat\u00e1rozni. K\u00e9szleten van Mesacol<\/a>, Mesacol OD<\/a> (napi egyszeri lass\u00fa felszabadul\u00e1s\u00fa dist\u00e1lis betegs\u00e9gre), \u00e9s Asacol<\/a> (ha k\u00e9szleten van). Topik\u00e1lis meszalamin (k\u00fap, hab) dist\u00e1lis proctitiszre a Gastro Health kateg\u00f3ri\u00e1ban tal\u00e1lhat\u00f3 Pentasa k\u00fapk\u00e9nt.\n\nSzulfaszalazin \u2014 IBD \u00e9s reumatoid arthritis kezel\u00e9s\u00e9re.<\/strong> A szulfaszalazin 5-ASA-t kombin\u00e1l szulfapiridinnel (egy azo-k\u00f6t\u00e9s\u0171 hordoz\u00f3, amely a vastagb\u00e9lben szabad\u00edtja fel az 5-ASA-t). Az ulcerat\u00edv colitisz szok\u00e1sos adagja napi 2\u20134 g osztott adagokban. K\u00e9szleten van Sazo<\/a> \u00e9s Salazar<\/a>. A tiszt\u00e1bb mell\u00e9khat\u00e1si profil\u00fa meszalamin \u00e1ltal\u00e1ban el\u0151ny\u00f6sebb IBD-re; a szulfaszalazin m\u00e9g mindig hasznos, ha IBD-hez t\u00e1rsul\u00f3 \u00edz\u00fcleti gyullad\u00e1s vagy reumatoid arthritis is fenn\u00e1ll (a szulfapiridin komponens DMARD hat\u00e1ssal rendelkezik).\n\nMebeverin \u2014 g\u00f6rcsold\u00f3 IBS-re.<\/strong> A mebeverin (egy simaizom-g\u00f6rcsold\u00f3) els\u0151 vonalbeli kezel\u00e9s\u0171 g\u00f6rcs\u00f6s \u00e9s g\u00f6rcsdomin\u00e1ns IBS eset\u00e9n \u2014 \u00e9tkez\u00e9s el\u0151tt 20 perccel kell bevenni. K\u00e9szleten van Colospa<\/a>. A mell\u00e9khat\u00e1si profil kedvez\u0151; szer\u00e9ny bizony\u00edt\u00e9kok \u00e1llnak rendelkez\u00e9sre r\u00e9gebbi vizsg\u00e1latokb\u00f3l.\n\nRifaximin \u2014 IBS-D \u00e9s SIBO kezel\u00e9s\u00e9re.<\/strong> A rifaximin egy nem felsz\u00edv\u00f3d\u00f3 lumenes antibiotikum, amely FDA \u00e1ltal j\u00f3v\u00e1hagyott IBS-D-re \u00e9s sz\u00e9lesebb k\u00f6rben haszn\u00e1latos b\u00e9lbakteri\u00e1lis t\u00faln\u00f6veked\u00e9s (SIBO) \u00e9s m\u00e1jencephalopathia eset\u00e9n. A kezel\u00e9s 550 mg naponta h\u00e1romszor 2 h\u00e9tig; a t\u00fcnetek javul\u00e1sa sok v\u00e1laszad\u00f3n\u00e1l h\u00f3napokig tart. K\u00e9szleten van Rifagut<\/a>.\n\nWhat's NOT here.<\/strong> Biologic therapy (infliximab, adalimumab, vedolizumab, ustekinumab, tofacitinib) for moderate-severe IBD requires specialist initiation and monitoring \u2014 not stocked. Corticosteroids for IBD flares: oral budesonide for ileal Crohn's and right-sided UC is in our Gastro Health category as Budez CR; systemic prednisolone is in Pain Relief Medication.\n\nHogyan v\u00e1lasszunk.<\/strong> Mild-moderate ulcerative colitis \u2192 oral mesalamine first-line + topical 5-ASA for distal disease + check adherence. Mild-moderate Crohn's \u2192 mesalamine has limited evidence (works in colonic disease only); budesonide for ileal disease. IBS-C (constipation-predominant) \u2192 osmotic \/ stimulant laxatives (see Constipation Medicine category) \u00b1 linaclotide \/ lubiprostone where available. IBS-D (diarrhoea-predominant) \u2192 rifaximin 2-week course; consider eluxadoline. IBS-M (mixed) \u2192 antispasmodic (mebeverine) + lifestyle \/ FODMAP diet trial. Refractory or alarm features (weight loss, blood, anaemia, age > 50, family history of IBD or CRC) \u2192 urgent gastroenterology referral.\n\nFontos.<\/strong> IBD flares require tighter management than IBS (significant disease can be silent on standard therapy, and untreated flares progress to complications including stricture, fistula, dysplasia, and need for colectomy). Annual review with calprotectin \/ endoscopy as appropriate. Pregnancy: most 5-ASAs and sulfasalazine are continued through pregnancy; folic acid supplementation needed for sulfasalazine. Methotrexate and many biologics carry pregnancy restrictions. New diarrhoea in IBD or worsening symptoms can be C. difficile \u2014 test before assuming flare.\n\nAll MedsBase IBS Treatment products ship from WHO-GMP tan\u00fas\u00edtv\u00e1nnyal rendelkez\u0151 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmazik<\/strong> diszkr\u00e9t csomagol\u00e1sban t\u00f6rt\u00e9nik, \u00e9s a \u00dajrak\u00fcld\u00e9si Garancia<\/a>.\n\n2026 buyer's guide:<\/strong> Tekintse meg r\u00f6vidlist\u00e1nkat Legjobb IBS & IBD kezel\u00e9sek 2026<\/a> rangsorolt aj\u00e1nl\u00e1sok\u00e9rt, \u00f6sszehasonl\u00edt\u00f3 t\u00e1bl\u00e1zat\u00e9rt, d\u00f3zisbe\u00e1ll\u00edt\u00e1si \u00fatmutat\u00e1s\u00e9rt \u00e9s d\u00f6nt\u00e9si r\u00f6vid\u00edt\u00e9s\u00e9rt.","link":"https:\/\/medsbase.com\/hu\/irritable-bowel-syndrome-ibs-treatment\/","name":"Ir\u00e1ny\u00edthatatlan b\u00e9l szindr\u00f3ma (IBS) kezel\u00e9se","slug":"irritable-bowel-syndrome-ibs-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/3565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product?product_cat=3565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}